Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 3, Status: Authorised juni 23, 2023 Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 3, Status: Authorised 2023-06-23 13:27:00 ema.europa.eu Human medicines European public assessment report (EPAR): Beyfortus, nirsevimab, Date of authorisation: 31/10/2022, Revision: 3, Status: Authorised Lees verder » Wil je het laatste nieuws in jouw mailbox? Meld je dan aan voor de nieuwsbrief. Delen Link ophalen Facebook Twitter Pinterest E-mail Andere apps Delen Link ophalen Facebook Twitter Pinterest E-mail Andere apps